RILABNACEPT Trademark

Trademark Overview


On Monday, January 8, 2024, a trademark application was filed for RILABNACEPT with the United States Patent and Trademark Office. The USPTO has given the RILABNACEPT trademark a serial number of 98346614. The federal status of this trademark filing is REGISTERED as of Tuesday, December 24, 2024. This trademark is owned by Hangzhou Gene-based Biopharmaceutical Co., Ltd.. The RILABNACEPT trademark is filed in the Advertising, Business and Retail Services category with the following description:

Advertising and advertisement services; Advertising, marketing and promotion services; Business appraisals; Commercial administration of the licensing of the goods and services of others; Import-export agency services; Influencer marketing services; Marketing services; Organization of exhibitions for commercial or advertising purposes; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies
rilabnacept

General Information


Serial Number98346614
Word MarkRILABNACEPT
Filing DateMonday, January 8, 2024
Status700 - REGISTERED
Status DateTuesday, December 24, 2024
Registration Number7619858
Registration DateTuesday, December 24, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 5, 2024

Trademark Statements


Goods and ServicesAdvertising and advertisement services; Advertising, marketing and promotion services; Business appraisals; Commercial administration of the licensing of the goods and services of others; Import-export agency services; Influencer marketing services; Marketing services; Organization of exhibitions for commercial or advertising purposes; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies
Translation of Words in MarkThe wording Rilabnacept has no meaning in a foreign language.

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, January 8, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHangzhou Gene-based Biopharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDist Hangzhou 311231
CN

Party NameHangzhou Gene-based Biopharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDist Hangzhou 311231
CN

Party NameHangzhou Gene-based Biopharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDist Hangzhou 311231
CN

Trademark Events


Event DateEvent Description
Monday, January 8, 2024NEW APPLICATION ENTERED
Thursday, April 25, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 2, 2024ASSIGNED TO EXAMINER
Monday, August 5, 2024NON-FINAL ACTION E-MAILED
Monday, August 5, 2024NON-FINAL ACTION WRITTEN
Monday, August 5, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 25, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 25, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 25, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 16, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 5, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 5, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 24, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED